PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1708723
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1708723
Global Myomectomy Market is estimated to be valued at USD 792.7 Mn in 2025 and is expected to reach USD 1,486.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 792.7 Mn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 9.40% | 2032 Value Projection: | USD 1,486.7 Mn |
A myomectomy is a surgical treatment that is used to remove noncancerous growths called uterine fibroids that grow in the uterus's muscular wall. Numerous symptoms, including pelvic pain, excessive monthly flow, and problems with fertility, can be brought on by these fibroids.
A myomectomy is a surgical procedure designed to specifically target and remove fibroids while preserving the integrity of the uterus. This is in contrast to a hysterectomy, where the entire uterus is removed. This makes myomectomy a reasonable alternative for women who prefer to keep their fertility or avoid the psychological and physiological impacts of a complete uterine removal. Depending on the quantity, location, and size of fibroids, the surgery can be carried out by using an abdominal, laparoscopic, or hysteroscopy method. For women with fibroid-related problems, a myomectomy can reduce symptoms and enhance the quality of their reproductive experience.
The myomectomy market is influenced by various dynamic factors. Increasing prevalence of uterine fibroids among women globally propels the market growth. Technological advancements in surgical techniques, such as the evolution of minimally invasive procedures like laparoscopic and hysteroscopic myomectomy, contribute to the expanding market. Growing awareness about women's health and fertility issues also drives demand for myomectomy procedures. Changing demographics, delayed pregnancies, and lifestyle factors impacting women's health contribute to the market's dynamics. Rise in healthcare expenditure, particularly in developed regions, supports the adoption of myomectomy procedures.